Multimodal imaging of Ewing sarcoma in a preclinical model demonstrates the advantage of immunoPET

J Dearling, T Tupper, R Modiste, G Dai, QD Nguyen… - 2015 - Soc Nuclear Med
1131 Objectives Localized Ewing sarcoma has an excellent 5-year event-free survival, but
patients with metastatic disease have a poor prognosis. Current imaging methods provide …

ImmunoPET compared with conventional imaging modalities for the detection of Ewing sarcoma metastases in a preclinical model.

AF O'Neill, JLJ Dearling, T Tupper, R Modiste, G Dai… - 2015 - ascopubs.org
10048 Background: Ewing sarcoma is a solid tumor arising from bone and the soft tissues
that affects approximately 250 children and adolescents each year. Localized disease …

Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model

C Franzius, M Hotfilder, C Poremba, S Hermann… - European journal of …, 2006 - Springer
Purpose As primary osseous metastasis is the main adverse prognostic factor in patients
with Ewing tumours, a NOD/scid mouse model for human Ewing tumour metastases has …

Targeted Imaging of Ewing Sarcoma in Preclinical Models Using a 64Cu-Labeled Anti-CD99 Antibody

AF O'Neill, JLJ Dearling, Y Wang, T Tupper, Y Sun… - Clinical Cancer …, 2014 - AACR
Purpose: Ewing sarcoma is a tumor of the bone and soft tissue characterized by diffuse cell
membrane expression of CD99 (MIC2). Single-site, surgically resectable disease is …

[HTML][HTML] Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging

L Liebsch, S Kailayangiri, L Beck, B Altvater… - British journal of …, 2013 - nature.com
Background: Novel treatment strategies in Ewing sarcoma include targeted cellular
therapies. Preclinical in vivo models are needed that reflect their activity against systemic …

121P Radiological staging with FDG-PET vs WB-MRI in Ewing sarcoma in the era of precision treatment

A Bassi, A Mitchell, J Gains, S Wan, S Singh, PS Lim - ESMO Open, 2024 - esmoopen.com
Background Baseline accurate assessment of metastatic disease is crucial in Ewing
sarcoma (ES) for determining treatment strategies. Advanced imaging, including 18F …

Ewing sarcoma

R Gupta, R Matthews, L Bangiyev, D Franceschi… - PET/MR Imaging: A …, 2018 - Springer
Ewing Sarcoma Page 1 9 © Springer International Publishing AG 2018 R. Gupta et al., PET/MR
Imaging, https://doi.org/10.1007/978-3-319-65106-4_4 Case 4 Ewing Sarcoma Apar Gupta …

In vitro and in vivo characterization of a preclinical irradiation-adapted model for ewing sarcoma

MC Shapiro, T Tang, A Dasgupta… - International Journal of …, 2018 - Elsevier
Purpose Radiation therapy (RT) is a viable therapeutic option for Ewing sarcoma (ES)
patients. However, little progress has been made to elucidate the mechanisms of …

[PDF][PDF] Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary Results. Diagnostics 2022, 12, 2278

M Chodyla, F Barbato, U Dirksen, J Kirchner… - 2022 - duepublico2.uni-due.de
Background: This study was conducted to evaluate the clinical applicability of integrated
PET/MRI for staging and monitoring the effectiveness of neoadjuvant chemotherapy in …

Early treatment response by FDG PET in patients with the Ewing sarcoma family of tumors predicts survival

JH Oo, J Leal, A Tahari, L Baker, R Wahl - 2013 - Soc Nuclear Med
Abstract 600 Objectives To assess the prognostic value of early FDG PET following therapy
in patients with Ewing sarcoma family of tumors (ESFT). Methods 115 patients from the …